The test analyzes 14 genetic pathways and 49 peptides to reveal how your body responds to GLP-1 signaling, including variants in GLP1R, GIPR, FTO, and MC4R genes
Generally, adults with a BMI of 30 or higher (classified as obese) or a BMI of 27 to 29.9 (classified as overweight) with at least one weight-related health condition are considered potential candidates
For example, constipation might start weeks after your first injection , even after you've gotten used to the initial wave of nausea
Talk to a provider about the right peptide stack or NAD+ dosing for your goals
Significant improvements in glycemic control were observed, with many participants achieving normal blood sugar levels
Payers expect details when notes allow